Depresszió: ki dolgozik rajta

Intézményenként egy kártya. Célpontra vagy országra szűkítheted a listát.

• Minden célpont
• BDNF 1
• NMDA 7
• NLRP3 0
• GLP-1 1
• IL-6 3
• TNF 0
• NRF2 0
• PPAR 0
• AMPK 0
• mTOR 0
• STAT3 0
• AKT 0
• JAK 1
• TLR4 0
• ERK 0
• IL-1 0
• PI3K 0
• AQP4 0
• HDAC 0
• HMGB1 0
• METTL3 0
• MMP-9 0
• SGLT2 0
• SIRT1 0
• VEGF 0
• BACE1 0
• C9orf72 0
• CCR5 0
• CD19 0
• CD22 0
• COX-2 0
• CTNNB1 0
• CXCR4 0
• DPP-4 0
• FOXP3 0
• HSP90 0
• IDO1 0
• IL-15 0
• IL-17 0
• IL-4 1
• MAPK 0
• MEK 0
• PARP 0
• PDGFR 0
• PINK1 0
• PRMT5 0
• RANKL 0
• SNCA 0
• STING 0
• TP53 0

1950 intézményből 24, a friss publikációk és a nyitott vizsgálatok szerint rendezve. Ez nem minőségi rangsor.

Funded research projects that name this disease in their title, terms or summary and have not ended yet: who is funded, where, how much and until when. Organisations only; the funder's page has the details.

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-GF

  Continuous Estrogen Monitoring Patch (EstroPatch)

  Katholieke Universiteit Leuven· Leuven, Belgium· EU contribution 321 301 EUR· until 2030. máj.· 2 countries

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-EF

  RANGE – Recombination And geNomic architecture in Genomic Erosion

  Kobenhavns Universitet· Kobenhavn, Dánia· EU contribution 247 553 EUR· until 2029. máj.

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-EF

  psiloNOVA: the new bridges by psilocybin to treat depression, from gut to brain (psilonova)

  Vilniaus Universitetas· Vilnius, Litvánia· EU contribution 181 136 EUR· until 2029. márc.

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-GF

  Leveraging POPulation genetic inferences to build actionable and equitable polygenic risk SCOREs for disease predictions (POPSCORE)

  Stichting Amsterdam Umc· Amsterdam, Hollandia· EU contribution 408 708 EUR· until 2029. dec.· 3 countries

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-EF

  Internalizing Networks: Working memory, ADHD, and emotion Regulation across adolescent Development (INWARD)

  Universiteit Van Amsterdam· Amsterdam, Hollandia· EU contribution 217 076 EUR· until 2028. nov.

  The disease is named only in the funder's project summary, not in the title.

5 of 108 running projects, newest first. Listed amounts together: 308,8 M EUR.

Sources: NIH RePORTER (U.S. National Institutes of Health, public domain) and CORDIS (European Commission, CC BY 4.0). Changes: filtered by disease, organisations matched to ROR.

Leállított, visszavont és felfüggesztett vizsgálatok, a szponzor által a regiszterben megadott okkal, szó szerint idézve.

• Visszavonták

  Acute Intermittent Hypoxia Therapy for Depression

  NCT07921654· Capital Medical University· Frissítve: 2026. nov. 10.

  “The study was withdrawn before enrollment of the first participant due to changes in the research plan.”A regiszter szövege, változtatás nélkül. Forrás

• Visszavonták

  Acceptability and Feasibility of Transcranial Magnetic Stimulation (TMS) for Depression in Multiple Sclerosis

  NCT06329414· University of Utah· Frissítve: 2026. nov. 6.

  “Recruitment Failure”A regiszter szövege, változtatás nélkül. Forrás

• Leállították

  Intensified Pharmacological Treatment for Schizophrenia, Major Depressive Disorder and Bipolar Depression After a First-time Treatment Failure

  NCT05603104· Dr. Inge Winter· Frissítve: 2026. nov. 5.

  “The site in Israel stopped recruitment due to logistic reasons. Other sites are recruiting for 2023-506602-39-00, 2023-506605-19-00, 2023-506617-21-00.”A regiszter szövege, változtatás nélkül. Forrás

• Visszavonták

  Linear Asymmetric rTMS in Adolescent Treatment-Resistant Depression: Treatment Durations From Ten Days to One Day

  NCT03986658· NeuroQore Inc.· Frissítve: 2026. nov. 2.

  “Due to a strategic decision by the sponsor, the study has been relocated to a different site, necessitating the withdrawal of this specific registration.”A regiszter szövege, változtatás nélkül. Forrás

• Visszavonták

  Ketamine Biomarker Validation

  NCT07307768· Soterix Medical· Frissítve: 2026. okt. 19.

  “Funding was not provided”A regiszter szövege, változtatás nélkül. Forrás

• Felfüggesztve

  Intermittent Theta Burst Stimulation for MDD

  NCT02506127· University of California, Los Angeles· Frissítve: 2026. okt. 16.

  “Protocol discontinued for futility”A regiszter szövege, változtatás nélkül. Forrás

• Leállították

  Network Analysis of Adult MDD and ADHD

  NCT04504474· Health Sciences North Research Institute· Frissítve: 2026. okt. 5.

  “The Health Sciences North Research Ethics Board (HSN REB) has recommended termination of approval for the research project, because it has surpassed the stated date of expiry for renewal.”A regiszter szövege, változtatás nélkül. Forrás

• Leállították

  Pilot Study of Personalized Aperiodic Transcranial Alternating Current Stimulation in Antenatal Depression (PandA-tACS)

  NCT06979154· University of North Carolina, Chapel Hill· Frissítve: 2026. szept. 28.

  “Due to lack of resources the study was terminated.”A regiszter szövege, változtatás nélkül. Forrás

• Felfüggesztve

  An Examination of the Performance of QbMobile in Differential Diagnosis Associated With ADHD Symptoms

  NCT07329673· Qbtech AB· Frissítve: 2026. szept. 25.

  “Enrollment/study activities have been temporarily suspended while the sponsor evaluates internal study priorities and resource allocation. The suspension is not related to participant safety, protocol compliance, data quality, or regulatory concerns.”A regiszter szövege, változtatás nélkül. Forrás

• Felfüggesztve

  A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease

  NCT04031469· ProgenaBiome· Frissítve: 2026. szept. 21.

  “Administrative”A regiszter szövege, változtatás nélkül. Forrás

Vizsgálatok, amelyek regiszteradata szerint az egyéni résztvevői adatokat (IPD) megosztják.

• Precision Depression Adalimumab Trial

  NCT07845604· Daniel Moriarity· Forrás

• Predicting Transitions From Depression to Wellbeing Through a Network-based Operationalization of Plasticity

  NCT07933276· IRCCS San Raffaele· Forrás

• Mechanism of Action Underlying Ketamine's Antidepressant Effects: The AMPA Throughput Theory in Patients With Treatment-Resistant Major Depression

  NCT03973268· National Institute of Mental Health (NIMH)· Forrás

• Preventive and Personalized Digital Emotion Regulation Skills Intervention to Reduce Depression and Anxiety in Youths With Adverse Childhood Experiences

  NCT07921446· Institute of Mental Health, Singapore· Forrás

• A Study to Assess the Change in Disease Activity and Adverse Events of AGN-151607-DP for the Treatment of Major Depressive Disorder in Adult Participants

  2025-525047-40-00· AbbVie Deutschland GmbH & Co. KG· Forrás

• A Study of Brenipatide in Participants With Major Depressive Disorder

  NCT07928245· Eli Lilly and Company· Forrás

• Understanding and Treating Suicidal Ideation With Ketamine

  NCT06891300· The Royal's Institute of Mental Health Research· Forrás

• Behavioural Activation Therapy and Ketamine for Treatment-Resistant Depression

  NCT07801703· The Royal's Institute of Mental Health Research· Forrás

• Natural History of Depression, Bipolar Disorder and Suicide Risk

  NCT06462196· National Institute of Mental Health (NIMH)· Forrás

• Optimizing Treatment for Depressed Parents of Children With Emotional and Behavioural Problems

  NCT07749521· University of Toronto· Forrás

Publikációk erről a betegségről egy MeSH-módszerkifejezés szerint, például szekvenálási vagy képalkotó módszerre.

• Single-Cell Analysis 15
• Mendelian Randomization Analysis 84
• CRISPR-Cas Systems 1
• Gene Expression Profiling 60
• Sequence Analysis, RNA 4
• Whole Genome Sequencing 1
• Exome Sequencing 4
• Proteomics 26
• Metabolomics 21
• Mass Spectrometry 2
• Flow Cytometry 1
• Immunohistochemistry 1
• Positron-Emission Tomography 25
• Magnetic Resonance Imaging 458
• Machine Learning 106
• Deep Learning 20
• Cohort Studies 126
• Genome-Wide Association Study 149

• Measuring the health benefits of genome and exome sequencing: a systematic review of economic evaluations.

  Front Public Health, 2026. jan.

Megmutatjuk, a betegség mely célpontjait említi az absztrakt, és onnan a rajtuk dolgozókhoz jutsz.